Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Acquires Cytonix

NEW YORK (GenomeWeb News) – Life Technologies recently acquired privately held Cytonix, a microfluidics technologies firm, the firm said earlier this week in its second-quarter earnings statement.

Life Technologies provided few details about the acquisition of the Beltsville, Md.-based company. However, it said that it acquired the firm for its intellectual property related to its microfluidics-based digital polymerase chain reaction technology.

Life Technologies also said that it plans to license the technology to partners as well as commercialize new products that can be used for applications ranging from next-generation sequencing library quantification to molecular diagnostic assays.

Last year, Cytonix's wholly-owned subsidiary, Genomic Nanosystems, licensed to Sequenom exclusive rights to use its digital PCR methods for non-invasive, prenatal diagnostic testing and sample analysis on any platform. In addition, Sequenom obtained exclusive rights to use digital PCR in conjunction with mass spectrometry for all commercial, diagnostic, or research applications except second-generation sequencing.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.